Pfizer Wins Approval For Tamper-Proof Pain Drug
Arlene Weintraub6/20/11
The FDA has approved a new form of the opioid oxycodone, which was developed by New York-based Pfizer (NYSE: PFE) and Palatine, IL-based Acura Pharmaceuticals (NASDAQ: ACUR), according to a press release. The product, branded as Oxeta, applies technology developed by Acura that is designed to discourage common methods of tampering associated with opioid abuse.
Pingback: Pfizer, Acura abuse-resistant painkiller gets FDA nod – Reuters | The Purse